Answers are grounded in this paper and cite their sources.
Progressive familial intrahepatic cholestasis(PFIC) encompasses a group of rare disorders that typically manifest in childhood with severe cholestasis.The spectrum of PFIC has expanded significantly in recent years.In adults, they exhibit considerable variability, with gene mutations being associated with cholestasis of pregnancy, low-phospholipid cholelithiasis, severe recurrent cholestasis, and recurrent drug-induced liver injury[1].Recently, the European Association for the Study of the Liver(EASL) proposed a position paper addressing the diagnosis and treatment of cholestatic diseases in children and adults[2].Odevixibat and Maralixibat ileal bile acid transporter inhibitors(IBAT-i), have been shown to effectively alleviate pruritus and reduce serum bile acid levels in children with PFIC, demonstrating high tolerability[3] also in real-life experiences[4].
No takes yet. Share an insight, caveat, or question.
Mandato et al. (2025) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: